Biocardia Stock Price on November 13, 2024
| BCDA Stock | USD 2.26 0.13 6.10% |
Below is the normalized historical share price chart for Biocardia extending back to November 13, 1996. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Biocardia stands at 2.26, as last reported on the 23rd of November, with the highest price reaching 2.32 and the lowest price hitting 2.14 during the day.
If you're considering investing in Biocardia Stock, it is important to understand the factors that can impact its price. Biocardia appears to be extremely dangerous, given 3 months investment horizon. Biocardia secures Sharpe Ratio (or Efficiency) of 0.0208, which signifies that the company had a 0.0208% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Biocardia, which you can use to evaluate the volatility of the firm. Please makes use of Biocardia's Risk Adjusted Performance of 0.0159, mean deviation of 6.3, and Downside Deviation of 7.2 to double-check if our risk estimates are consistent with your expectations.
At present, Biocardia's Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 1.2 M, whereas Total Stockholder Equity is projected to grow to (1.5 M). . As of November 23, 2024, Price To Sales Ratio is expected to decline to 28.01. The current year's Price Earnings Ratio is expected to grow to -1.15. Biocardia Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 14th of March 2008 | 200 Day MA 4.1287 | 50 Day MA 2.55 | Beta 1.272 |
Biocardia |
Sharpe Ratio = 0.0208
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BCDA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 12.3 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.26 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Biocardia is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biocardia by adding it to a well-diversified portfolio.
Price Book 3.5552 | Enterprise Value Ebitda (3.16) | Price Sales 22.8678 | Shares Float 1.6 M | Wall Street Target Price 25 |
Biocardia Main Headline on 13th of November 2024
BioCardia Reports Third Quarter 2024 Business Highlights and... by finance.yahoo.com
SUNNYVALE, Calif., Nov. 13, 2024 -- BioCardia, Inc. Nasdaq BCDA, a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the third quarter of 2024 and filed its quarterly report on Form 10-Q for the three and nine months ended September 30, 2024 with the Securities and Exchange Commission. The Company will also hold a conference call at 430 PM ET today in which it will discuss busi
Biocardia Valuation on November 13, 2024
It is possible to determine the worth of Biocardia on a given historical date. On November 13, 2024 Biocardia was worth 2.4 at the beginning of the trading date compared to the closed value of 2.35. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Biocardia stock. Still, in general, we apply an absolute valuation method to find Biocardia's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Biocardia where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Biocardia's related companies.
| Open | High | Low | Close | Volume | |
| 2.21 | 2.45 | 2.21 | 2.40 | 29,433 | |
11/13/2024 | 2.40 | 2.47 | 2.35 | 2.35 | 56,883 |
| 2.29 | 2.36 | 2.01 | 2.02 | 152,188 |
| Backtest Biocardia | | | Biocardia History | | | Biocardia Valuation | Previous | Next |
Biocardia Trading Date Momentum on November 13, 2024
| On November 14 2024 Biocardia was traded for 2.02 at the closing time. The top price for the day was 2.36 and the lowest listed price was 2.01 . The trading volume for the day was 152.2 K. The trading history from November 14, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 14.04% . The overall trading delta against the current closing price is 8.51% . |
Biocardia Fundamentals Correlations and Trends
By evaluating Biocardia's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Biocardia's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Biocardia financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Biocardia Stock history
Biocardia investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Biocardia is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Biocardia will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Biocardia stock prices may prove useful in developing a viable investing in Biocardia
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.4 M | 1.4 M | |
| Net Loss | -10.7 M | -11.3 M |
Biocardia Stock Technical Analysis
Biocardia technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Biocardia Period Price Range
Low | November 23, 2024
| High |
0.00 | 0.00 |
Biocardia cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Biocardia November 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Biocardia stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biocardia shares will generate the highest return on investment. By undertsting and applying Biocardia stock market strength indicators, traders can identify Biocardia entry and exit signals to maximize returns
Biocardia Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Biocardia's price direction in advance. Along with the technical and fundamental analysis of Biocardia Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Biocardia to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0159 | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (1.50) | |||
| Sortino Ratio | (0.0007) | |||
| Treynor Ratio | 0.0374 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Biocardia Stock analysis
When running Biocardia's price analysis, check to measure Biocardia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocardia is operating at the current time. Most of Biocardia's value examination focuses on studying past and present price action to predict the probability of Biocardia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biocardia's price. Additionally, you may evaluate how the addition of Biocardia to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |